Related Experiment Video

Updated: Jul 16, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Regulatory aspects of oncolytic virus products

Teruhide Yamaguchi1, Eriko Uchida

  • 1Division of Biological Chemistry and Biologicals, The National Institute of Health Sciences, Kamiyoga 1-18-1, Setagaya, Tokyo, 158-8501, Japan. yamaguch@nihs.go.jp

Current Cancer Drug Targets
|March 10, 2007
PubMed

Insights

Oncolytic viruses offer innovative cancer therapy, but their unique development, manufacturing, and clinical study present distinct regulatory challenges. Ensuring safety and efficacy requires specialized approaches and advanced characterization technologies.

Area of Science:

  • Oncology
  • Virology
  • Biotechnology
  • Regulatory Science

Background:

  • Oncolytic viruses represent an innovative approach to cancer therapy, encompassing wild-type, attenuated, and genetically modified strains.
  • These viral agents possess distinct strategies, natures, and technologies compared to traditional gene or cancer therapies.
  • Regulatory oversight is crucial for ensuring the safety, efficacy, and quality of oncolytic virus products.

Purpose of the Study:

  • To outline key considerations and challenges in the development, manufacturing, and clinical application of oncolytic viruses.
  • To highlight regulatory aspects critical for oncolytic virus product approval.
  • To identify areas requiring further research and technological advancement for oncolytic virus characterization and safety assurance.

Main Methods:

  • Review of current strategies in oncolytic virus design, including wild-type, attenuated, and genetically engineered strains.
  • Analysis of critical points in the development pipeline: proof of concept, manufacturing, characterization, non-clinical, and clinical studies.
  • Examination of specific issues such as virus selectivity, animal model relevance, clinical safety, and virus shedding evaluation.

Main Results:

  • Oncolytic virus development involves unique challenges distinct from conventional therapies.
  • Key issues span virus design, proof of concept, target selectivity, animal models, clinical safety, and shedding evaluation.
  • Current knowledge is insufficient, necessitating unique safety approaches and novel characterization technologies.

Conclusions:

  • The development of oncolytic viruses requires careful consideration of specific design, preclinical, and clinical factors.
  • Ensuring the safety and efficacy of these novel therapeutics necessitates unique regulatory strategies and advanced characterization methods.
  • Further research and technological innovation are essential to fully realize the potential of oncolytic virus therapy.

More Related Videos

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy08:51

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

Growth, Purification, and Titration of Oncolytic Herpes Simplex Virus06:14

Growth, Purification, and Titration of Oncolytic Herpes Simplex Virus

Published on: May 13, 2021

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Regulation of Bacterial Virulence01:28

Regulation of Bacterial Virulence

Pathogenic bacteria employ a range of regulatory mechanisms to modulate the expression of virulence genes in response to environmental and host-derived signals. These mechanisms ensure that virulence factors are expressed only under favorable conditions, thereby optimizing infection and survival strategies.Mechanisms of Virulence RegulationKey regulatory strategies include:Two-Component Systems: These consist of a membrane-bound sensor kinase and a cytoplasmic response regulator. Environmental...
Drug Regulation01:25

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.